Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 1.000 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.572 | |
4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.569 | |
3efw | AK8 | Aurora kinase A | 2.7.11.1 | 0.568 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.566 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.558 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.558 | |
3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.558 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.557 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.556 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.556 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.553 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.553 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.550 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.543 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.538 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.537 | |
3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.537 | |
1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.535 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.533 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.533 | |
4gu6 | 10N | Focal adhesion kinase 1 | 2.7.10.2 | 0.533 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.532 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.532 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.532 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.531 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.530 | |
2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.529 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.529 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.529 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.529 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.529 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.528 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.528 | |
2e9p | 77A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.527 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.527 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.527 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.526 | |
4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.525 | |
4b8l | A0P | Aurora kinase B-A | 2.7.11.1 | 0.524 | |
2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.522 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.522 | |
2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.521 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.521 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.521 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.520 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.520 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.520 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.519 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.519 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.519 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.519 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.518 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.518 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.517 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.516 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.515 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.515 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.514 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.514 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.514 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.514 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.513 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.513 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.513 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.513 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.513 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.512 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.512 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.512 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.512 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.511 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.510 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.510 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.509 | |
3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.509 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.509 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.509 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.508 | |
4brx | KGW | Focal adhesion kinase 1 | 2.7.10.2 | 0.508 | |
1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.507 | |
1z5m | LI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.507 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.507 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.507 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.506 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.506 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.506 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.506 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
3nlb | 5BE | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.503 | |
1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.503 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.503 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.502 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.502 | |
3fz1 | B98 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.502 | |
3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.501 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.500 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.500 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.500 | |
4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.500 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.500 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.499 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.499 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.499 | |
2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.499 | |
2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.499 | |
4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.499 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.498 | |
3otu | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.498 | |
4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.498 | |
4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.498 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
3t8o | ATP | Rhodopsin kinase | / | 0.497 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.497 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.496 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.496 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.496 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.496 | |
4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.496 | |
4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.496 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.495 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.495 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.495 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.495 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.494 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.494 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.494 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.493 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.492 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.492 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.492 | |
4hyi | 1AO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.492 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.491 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.491 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.491 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.491 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
2jko | BIJ | Focal adhesion kinase 1 | 2.7.10.2 | 0.490 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.490 | |
2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
4d58 | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.490 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.490 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.490 | |
1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.489 | |
1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.489 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.489 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.489 | |
1ykr | 628 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.488 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.488 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.488 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
4y95 | 746 | Tyrosine-protein kinase | / | 0.488 | |
1zlt | HYM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.487 | |
3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.487 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.487 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.487 | |
4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.487 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.487 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.486 | |
2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.486 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.486 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.486 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.486 | |
2wmv | ZYV | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.485 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.485 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.484 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
4fto | 3HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.484 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.484 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.483 | |
1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.483 | |
2bkz | SBC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
2c5n | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.483 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.483 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.483 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.483 | |
4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.483 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.483 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.482 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.482 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.482 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.482 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.481 | |
4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.481 | |
4nif | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.481 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
2jkq | VG8 | Focal adhesion kinase 1 | 2.7.10.2 | 0.480 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
4e93 | GUI | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.480 | |
4eol | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.480 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.480 | |
5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.480 | |
2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.479 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.479 | |
2xru | 400 | Aurora kinase A | 2.7.11.1 | 0.479 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.479 | |
3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.479 | |
3c4z | ADP | Rhodopsin kinase | / | 0.479 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.479 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.479 | |
4d4s | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.479 | |
4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.478 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.478 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.477 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.477 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.477 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.477 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.477 | |
4eoi | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
5auv | AGI | Death-associated protein kinase 1 | 2.7.11.1 | 0.477 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.476 | |
2ds1 | 1CD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
2vgp | AD6 | Aurora kinase B-A | 2.7.11.1 | 0.476 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.476 | |
3zmm | F9J | Tyrosine-protein kinase JAK2 | / | 0.476 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.476 | |
2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.475 | |
3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.475 | |
4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.475 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.475 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.475 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.475 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.474 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.474 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.474 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.474 | |
4bde | CWS | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.474 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
4erk | OLO | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.474 | |
4ftq | 4HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
1wvy | STU | Death-associated protein kinase 1 | 2.7.11.1 | 0.473 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.473 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.473 | |
4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.473 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.473 | |
4ek8 | 16K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
4ewh | T77 | Activated CDC42 kinase 1 | / | 0.473 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.473 | |
4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.473 | |
5aux | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.473 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.472 | |
2cn8 | DBQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.472 | |
2cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.472 | |
2wmr | ZYR | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.472 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.472 | |
4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.472 | |
4fks | 46K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.472 | |
4wbo | ANW | Rhodopsin kinase | / | 0.472 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.472 | |
1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.471 | |
2j50 | 627 | Aurora kinase A | 2.7.11.1 | 0.471 | |
2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
2wtj | WTJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.471 | |
2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
2ydk | YDK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.471 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.471 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.471 | |
1iwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.470 | |
1mp8 | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.470 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
2j4z | 626 | Aurora kinase A | 2.7.11.1 | 0.470 | |
2w1e | L0E | Aurora kinase A | 2.7.11.1 | 0.470 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.470 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.470 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.470 | |
3r7i | X9I | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
4a9t | A9T | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.470 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.470 | |
4kio | G5K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.470 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.469 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.469 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.469 | |
3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
4a9u | A9U | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.469 | |
4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.469 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.469 | |
4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.469 | |
4i41 | MIX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.469 | |
4krc | AGS | Cyclin-dependent protein kinase PHO85 | 2.7.11.22 | 0.469 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.468 | |
1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
2b52 | D42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3r8l | Z30 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.468 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.468 | |
4ccu | AWF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.468 | |
4ekl | 0RF | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.468 | |
4eom | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
4fkr | 45K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
4hyh | 1AM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.468 | |
5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.468 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
2c6t | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.467 | |
2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
3c4x | ATP | Rhodopsin kinase | / | 0.467 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.467 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.467 | |
3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.467 | |
3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.467 | |
3qwk | X62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.467 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.467 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.467 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.467 | |
1phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.466 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.466 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.466 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.466 | |
3q5i | ANP | Protein kinase, putative | / | 0.466 | |
3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
3qqf | X07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
3w55 | 1FM | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.466 | |
4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
5dr2 | ATP | Aurora kinase A | 2.7.11.1 | 0.466 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.465 | |
2b53 | D23 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
2yex | YEX | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
3ekx | 1UN | Gag-Pol polyprotein | 3.4.23.16 | 0.465 | |
3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.465 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.465 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.465 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.465 | |
5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.465 | |
1snu | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.464 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.464 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.464 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.464 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
3el5 | 1UN | Gag-Pol polyprotein | / | 0.464 | |
3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.464 | |
3w16 | P9J | Aurora kinase A | 2.7.11.1 | 0.464 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.464 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.464 | |
4jrn | ANP | Rhoptry kinase family protein | / | 0.464 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.463 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.463 | |
2qkr | IXM | Cdc2-like CDK2/CDC28 like protein kinase | / | 0.463 | |
2r3i | SCF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
2r43 | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.463 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.463 | |
3rpv | 26Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.463 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.463 | |
5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.463 | |
2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.462 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.462 | |
3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.462 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.462 | |
3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
3r7e | X88 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.462 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.462 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.462 | |
4eop | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
1geb | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.461 | |
2azz | TCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.461 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.461 | |
3lq5 | SLQ | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.461 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.461 | |
4c3r | ACP | Aurora kinase A | 2.7.11.1 | 0.461 | |
4fmq | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.461 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.461 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.461 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.461 | |
1h1q | 2A6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.460 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
2oj9 | BMI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.460 | |
2r3p | 3SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.460 | |
2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
3dcv | 55E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
3kga | LX9 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.460 | |
3qcx | 3Q2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
3r73 | X87 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.460 | |
5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.460 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.460 | |
5l8j | ADP | Aurora kinase A | 2.7.11.1 | 0.460 | |
1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.459 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.459 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
3rk5 | 07Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
4deg | 0JJ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.459 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.459 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.459 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.459 | |
4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.459 | |
4zol | ACP | Tubulin tyrosine ligase | / | 0.459 | |
5dpv | SKE | Aurora kinase A | 2.7.11.1 | 0.459 | |
5dt0 | SKE | Aurora kinase A | 2.7.11.1 | 0.459 | |
1d7l | RFL | p-hydroxybenzoate hydroxylase | / | 0.458 | |
1ol6 | ATP | Aurora kinase A | 2.7.11.1 | 0.458 | |
2b9j | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.458 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.458 | |
3c4w | ATP | Rhodopsin kinase | / | 0.458 | |
3dfc | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.458 | |
3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.458 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
3qyw | 6PB | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
3qzh | X69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.458 | |
4a7c | E46 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
4acm | 7YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
4i0s | 1B5 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.458 | |
4oh4 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.458 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.458 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.458 | |
1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.457 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
2xng | A0H | Aurora kinase A | 2.7.11.1 | 0.457 | |
3cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.457 | |
3lfs | A07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
3lix | E17 | Protease | / | 0.457 | |
4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.457 | |
4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.457 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.457 | |
1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.456 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.456 | |
2vto | LZ8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.456 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2xne | ASH | Aurora kinase A | 2.7.11.1 | 0.456 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.456 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.456 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.456 | |
4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.455 | |
2xj1 | XJ1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.455 | |
3el4 | ROC | Gag-Pol polyprotein | 3.4.23.16 | 0.455 | |
3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.455 | |
4dta | ADN | APH(2'')-Id | / | 0.455 | |
4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.455 | |
4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.455 | |
1pxo | CK7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.454 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.454 | |
2c5y | MTW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2jkk | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.454 | |
2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2w1g | L0G | Aurora kinase A | 2.7.11.1 | 0.454 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.454 | |
3mpj | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.454 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.454 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.454 | |
4qmu | SKE | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.454 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.454 | |
1izi | Q50 | Gag-Pol polyprotein | 3.4.23.16 | 0.453 | |
1ke7 | LS3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
1tqm | ANP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.453 | |
2bmc | MPY | Aurora kinase A | 2.7.11.1 | 0.453 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3bhy | 7CP | Death-associated protein kinase 3 | / | 0.453 | |
3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.453 | |
3h3c | P1E | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.453 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.453 | |
3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.453 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3qql | X03 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3r7y | Z04 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.453 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
4mf1 | 29Y | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.453 | |
4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.453 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
2c6i | DT1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.452 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.452 | |
2uze | C95 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.452 | |
3r1y | X76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.452 | |
4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.452 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
4cfn | JYM | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.452 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.452 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.452 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
4xld | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
1v0o | INR | Cell division control protein 2 homolog | 2.7.11.22 | 0.451 | |
3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.451 | |
3roy | 22Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
4lyn | 1YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
5dt4 | ATP | Aurora kinase A | 2.7.11.1 | 0.451 | |
5l8k | ADP | Aurora kinase A | 2.7.11.1 | 0.451 | |
1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
1phh | FAD | p-hydroxybenzoate hydroxylase | / | 0.450 | |
2pul | ACP | Methylthioribose kinase | 2.7.1.100 | 0.450 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2wip | P49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.450 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.450 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
3ti1 | B49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3v8t | 477 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.450 | |
4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.450 | |
4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.450 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.450 | |
4fkl | CK2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
4ivd | 15T | Tyrosine-protein kinase JAK1 | / | 0.450 | |
4iwd | 1JC | Hepatocyte growth factor receptor | 2.7.10.1 | 0.450 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
1phe | PIY | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.449 | |
2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.449 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.449 | |
2pml | ANP | Uncharacterized protein | / | 0.449 | |
2pwc | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
2r5t | ANP | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.449 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
3bht | MFR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.449 | |
3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.449 | |
3m42 | HGF | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.449 | |
3nuy | JPZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
4ijp | 1EH | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.449 | |
4jik | 1KO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
4l4c | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.449 | |
5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.449 | |
5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.449 | |
1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.448 | |
1ol5 | ADP | Aurora kinase A | 2.7.11.1 | 0.448 | |
1pxp | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
2gdo | 12C | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
2qak | 1UN | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.448 | |
2uzn | C96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.448 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.448 | |
3ggu | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.448 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.448 | |
3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3uli | 1N3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
4e1z | 0MX | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.448 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.448 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.448 | |
4wh3 | ATP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.448 | |
5av4 | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
1y91 | CT9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2bhh | RYU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.447 | |
2uzo | C62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3ral | 04Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.447 | |
4bzo | 676 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
4c9p | CAM | Cytochrome P450 | / | 0.447 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.447 | |
4fkw | 62K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4ix6 | ADP | Uncharacterized protein | / | 0.447 | |
4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.447 | |
4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.447 | |
1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
2j9m | PY8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.446 | |
2pyw | ADP | Methylthioribose kinase | 2.7.1.100 | 0.446 | |
3sqq | 99Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3vsp | EK8 | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
4bie | IE6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.446 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.446 | |
4k6z | 1Q3 | Tyrosine-protein kinase JAK1 | / | 0.446 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.446 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
1ol7 | ADP | Aurora kinase A | 2.7.11.1 | 0.445 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.445 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.445 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.445 | |
3igg | EFQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.445 | |
4eb4 | D16 | Thymidylate synthase | 2.1.1.45 | 0.445 | |
4eon | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4eos | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.445 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.445 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
1pxl | CK4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.444 | |
2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.444 | |
2xmy | CDK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3i81 | EBI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.444 | |
3jpv | 1DR | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
3rjc | 06Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3zlx | 5EZ | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.444 | |
3zze | 6XP | Hepatocyte growth factor receptor | 2.7.10.1 | 0.444 | |
4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.444 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
4fg8 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.444 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
4l4f | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.444 | |
4qi7 | FAD | Cellobiose dehydrogenase | / | 0.444 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.444 | |
1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.443 | |
1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.443 | |
2a4l | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2b7z | MK1 | Gag-Pol polyprotein | / | 0.443 | |
2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.443 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
2pqz | G0G | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
2wgj | VGH | Hepatocyte growth factor receptor | 2.7.10.1 | 0.443 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.443 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.443 | |
3r02 | UNM | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
4a9r | RU5 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.443 | |
4dea | NHI | Aurora kinase A | 2.7.11.1 | 0.443 | |
4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.443 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.443 | |
1bsv | NDP | GDP-L-fucose synthase | / | 0.442 | |
1h1p | CMG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
1jkk | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.442 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
2bpv | 1IN | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.442 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.442 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.442 | |
3qrs | NK8 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
3r1s | X73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
3zdu | 38R | Cyclin-dependent kinase-like 3 | 2.7.11.22 | 0.442 | |
4fkg | 4CK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.442 | |
4utd | ACP | Aurora kinase A | 2.7.11.1 | 0.442 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.442 | |
4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.442 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
1gy3 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1j7u | ANP | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.441 | |
1u3d | FAD | Cryptochrome-1 | / | 0.441 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.441 | |
1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.441 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.441 | |
2np8 | CC3 | Aurora kinase A | 2.7.11.1 | 0.441 | |
2r38 | G4G | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.441 | |
2yaa | ATP | Death-associated protein kinase 2 | / | 0.441 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.441 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.441 | |
3qro | NK9 | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
3qrt | X14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
4bgh | 3I6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.441 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.441 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.441 | |
4n57 | ADP | APH(2'')-Id | / | 0.441 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.441 | |
1meu | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
1mru | AGS | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.440 | |
1w0x | OLO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.440 | |
2oji | 33A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
2ojj | 82A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
3bgz | VX3 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
3dnd | LL2 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.440 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
3o0g | 3O0 | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.440 | |
3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.440 | |
3r8v | Z62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3s1c | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.440 | |
3uo5 | 0BX | Aurora kinase A | 2.7.11.1 | 0.440 | |
4ap7 | F47 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.440 | |
4ckj | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.440 | |
4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.440 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
4gg5 | 0J3 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.440 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.440 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.440 |